Prevymis (letermovir) concentrate for solution for infusion - Essential to administer through sterile 0.2 micron or 0.22 micron polyethersulfone (PES) in-line filter
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Medicine name |
Prevymis
|
Active substance |
Letermovir
|
Therapeutic area (MeSH) |
Cytomegalovirus Infections
|
Procedure number |
II/16/G
|
Regulatory outcome |
Variation
|
Human ATC code |
J05
|